By Toni Clarke
(Reuters) - The U.S. Food and Drug Administration has approved a long-acting narcotic painkiller with abuse-resistant properties made by Purdue Pharma L.P., the agency said on Thursday.
The FDA approved the once-daily drug, hydrocodone bitartrate (Hysingla ER), with the expectation that it will reduce, though not necessarily prevent, abuse through snorting or injecting.
It is the second extended-release single-entity hydrocodone drug approved by the FDA. The first, approved last October, was Zohydro ER, made by San Diego-based Zogenix Inc.